APA (7th ed.) Citation

Jenzer, M., Keß, P., Nientiedt, C., Endris, V., Kippenberger, M., Leichsenring, J., . . . Duensing, S. (2019). The BRCA2 mutation status shapes the immune phenotype of prostate cancer. Cancer immunology immunotherapy, 68(10), . https://doi.org/10.1007/s00262-019-02393-x

Chicago Style (17th ed.) Citation

Jenzer, Maximilian, et al. "The BRCA2 Mutation Status Shapes the Immune Phenotype of Prostate Cancer." Cancer Immunology Immunotherapy 68, no. 10 (2019). https://doi.org/10.1007/s00262-019-02393-x.

MLA (9th ed.) Citation

Jenzer, Maximilian, et al. "The BRCA2 Mutation Status Shapes the Immune Phenotype of Prostate Cancer." Cancer Immunology Immunotherapy, vol. 68, no. 10, 2019, https://doi.org/10.1007/s00262-019-02393-x.